<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01271257</url>
  </required_header>
  <id_info>
    <org_study_id>CMUBH R990011</org_study_id>
    <secondary_id>DMR-IRB-242</secondary_id>
    <nct_id>NCT01271257</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Misoprostol With Titrated Oral Administration</brief_title>
  <official_title>Phase 1 Study of Titrated Oral Misoprostol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The AUC240, AUC360, and AUC480 of titrated oral misoprostol are greater than traditional oral
      misoprostol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary outcomes measures of the study are the area under the curve of serum
      concentration of misoprostol acid against time up to 240, 360 and 480 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AUC480 (the area under the curve of serum concentration of misoprostol acid against time up to 480 minutes)</measure>
    <time_frame>480 min post start of oral misoprostol administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUC240 (the area under the curve of serum concentration of misoprostol acid against time up to 240 minutes)</measure>
    <time_frame>240 min post start of oral misoprostol administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC360 (the area under the curve of serum concentration of misoprostol acid against time up to 360 minutes)</measure>
    <time_frame>360 min post start of oral misoprostol administration</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Hypotonic; Labor</condition>
  <arm_group>
    <arm_group_label>hourly misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 microgram misoprostol intake per hour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>traditional misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>80 microgram misoprostol intake per 4 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>20 microgram PO per hour for 8 doses or 80 microgram PO per 4 hours for 2 doses</description>
    <arm_group_label>hourly misoprostol</arm_group_label>
    <arm_group_label>traditional misoprostol</arm_group_label>
    <other_name>cytotec</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20-40 Y/O healthy and non-pregnant woman

        Exclusion Criteria:

          -  heart, liver or kidney disease, anaphylaxis to misoprostol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shi-Yann Cheng, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Medical University Beigang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>China Medical University Beigang Hospital</name>
      <address>
        <city>Yunlin Xian</city>
        <zip>651</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>http://www.bh.cmu.edu.tw/cmubh/ch/index.php</url>
    <description>China Medical University Beigang Hospital</description>
  </link>
  <reference>
    <citation>Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002 Feb;17(2):332-6.</citation>
    <PMID>11821273</PMID>
  </reference>
  <reference>
    <citation>Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997 Jul;90(1):88-92.</citation>
    <PMID>9207820</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2011</study_first_submitted>
  <study_first_submitted_qc>January 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2011</study_first_posted>
  <last_update_submitted>January 27, 2016</last_update_submitted>
  <last_update_submitted_qc>January 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University Hospital</investigator_affiliation>
    <investigator_full_name>Shi-Yann Cheng</investigator_full_name>
    <investigator_title>Director of Department of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>misoprostol, pharmacokinetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

